Saxenda fatigue: side effect or sign something's wrong?

What did @vero_avud actually say?

Honestly? Not much, medically speaking. The transcript here is a joke, not a health claim. @vero_avud said: "The good news is there's no more plague, ha-zah! The bad news is there's no more London." That's a historical comedy bit, almost certainly from a TV show or stand-up routine, with zero direct connection to Saxenda, liraglutide, or fatigue management.

The actual claim lives in the caption, not the spoken words. The creator frames fatigue as "the side effect you got dealt" on Saxenda, implying it's a common, somewhat random fate for users of the drug. That framing, combined with a comedic deflection in the video itself, is worth examining on its own terms, even if the transcript gives us nothing clinical to work with.

Does the science back this up?

On the caption's premise, yes, fatigue is a documented Saxenda side effect, though the evidence suggests it's far from universal. The clinical picture is more specific than "you just get dealt it."

The SCALE Obesity and Prediabetes trial (Pi-Sunyer et al., 2015, New England Journal of Medicine) followed over 3,700 participants on liraglutide 3.0 mg for 56 weeks. Fatigue was reported as an adverse event, but nausea, vomiting, and diarrhea dominated the side effect profile by a significant margin. Fatigue on its own wasn't among the top-tier complaints in that dataset.

A 2021 review by Jensterle et al. in Obesity Reviews looked at GLP-1 receptor agonist tolerability broadly and found that fatigue reports tend to cluster around dose escalation periods, not as a persistent baseline experience. In other words, the mechanism matters: reduced caloric intake, early GI disruption, and the body's adjustment to slower gastric emptying can all contribute to low energy, especially in the first few weeks.

What did they get wrong (or right)?

The caption gets the basic fact right: fatigue does happen on Saxenda. Credit where it's due. But "the side effect you got dealt" implies randomness or inevitability that the data doesn't fully support.

Whether someone experiences fatigue on liraglutide is influenced by dose timing, hydration, caloric deficit size, sleep quality, and individual GLP-1 receptor sensitivity. Treating it as a lottery outcome, rather than something with identifiable contributing factors, undersells the practical options users have to manage it.

What's missing from the caption framing is any acknowledgment that fatigue often tracks with how aggressively someone is cutting calories alongside the medication, or with the nausea-driven appetite suppression that discourages eating enough to maintain energy. That's not a minor omission if 10,000 people are watching and some may conclude fatigue is just something to accept passively.

What should you actually know?

If you're on Saxenda and dealing with fatigue, the first questions worth asking are practical ones. Are you eating enough to support basic metabolic function? GLP-1 agonists suppress appetite strongly, and some users undereat significantly, which compounds tiredness. The drug does the heavy lifting on appetite; you still need adequate protein and micronutrients.

Timing also matters. Some users report better energy profiles when injecting in the evening rather than the morning, though this varies. Talk to your prescriber before changing injection timing.

Fatigue that persists beyond the first 4-8 weeks of dose escalation, or that's severe enough to interfere with daily function, is worth flagging explicitly. It can occasionally signal something else, including thyroid changes or iron deficiency, that isn't caused by the drug but gets noticed during treatment because people are paying closer attention to their bodies.

Finally, the comedic framing in this video, while clearly not intended as medical advice, reflects a broader social media pattern of normalizing side effects without context. Relatability is fine. Passive acceptance of manageable symptoms, without knowing there are strategies to address them, is less helpful.